{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:36:49Z","timestamp":1790041009609,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jconrel.2025.01.047","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:37:50Z","timestamp":1738355870000},"page":"982-992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Targeting antibodies dissociate from drug delivery liposomes during blood circulation"],"prefix":"10.1016","volume":"379","author":[{"given":"Unnur J.","family":"Bj\u00f6rgvinsd\u00f3ttir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannik B.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Andresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus","family":"M\u00fcnter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.01.047_bb0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jconrel.2023.02.010","article-title":"Targeted nanomedicine: lessons learned and future directions","volume":"355","author":"Veiga","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.01.047_bb0010","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41416-018-0235-2","article-title":"Safety and pharmacokinetics of MM-302, a HER2-targeted antibody\u2013liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study","volume":"119","author":"Munster","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.01.047_bb0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0005-2736(01)00351-0","article-title":"Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes","volume":"1513","author":"Li","year":"2001","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembr."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2025.01.047_bb0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijpharm.2017.11.010","article-title":"Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption","volume":"536","author":"Yamamoto","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0030","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.actbio.2021.06.008","article-title":"Isolation methods commonly used to study the liposomal protein corona suffer from contamination issues","volume":"130","author":"Kristensen","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0035","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1002\/anie.202004611","article-title":"Pay attention to biological nanoparticles when studying the protein Corona on nanomedicines","volume":"59","author":"Simonsen","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jconrel.2009.02.002","article-title":"Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage","volume":"136","author":"Shmeeda","year":"2009","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2025.01.047_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0050","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1021\/acsnano.5b03300","article-title":"In vivo biomolecule Corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles","volume":"9","author":"Hadjidemetriou","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.01.047_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/acsabm.2c00830","article-title":"Single-particle functionality imaging of antibody-conjugated nanoparticles in complex media","volume":"6","author":"Woythe","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.addr.2020.09.003","article-title":"When liposomes met antibodies: drug delivery and beyond","volume":"154\u2013155","author":"Di","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0065","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/bc900448f","article-title":"Influence of multivalent nitrilotriacetic acid lipid-ligand affinity on the circulation half-life in mice of a liposome-attached His6-protein","volume":"21","author":"Platt","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0070","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/acs.bioconjchem.8b00033","article-title":"Quantitation and stability of protein conjugation on liposomes for controlled density of surface epitopes","volume":"29","author":"Chen","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1021\/acs.molpharmaceut.0c00149","article-title":"In vitro and in vivo behavior of liposomes decorated with PEGs with different chemical features","volume":"17","author":"Mastrotto","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0080","doi-asserted-by":"crossref","first-page":"22720","DOI":"10.1039\/C8NR07755J","article-title":"Dissociation of fluorescently labeled lipids from liposomes in biological environments challenges the interpretation of uptake studies","volume":"10","author":"M\u00fcnter","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2025.01.047_bb0085","doi-asserted-by":"crossref","first-page":"2106529","DOI":"10.1002\/smll.202106529","article-title":"Unravelling heterogeneities in complement and antibody Opsonization of individual liposomes as a function of surface architecture","volume":"18","author":"M\u00fcnter","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.01.047_bb0090","doi-asserted-by":"crossref","DOI":"10.3791\/60538","article-title":"A quantitative fluorescence microscopy-based single liposome assay for detecting the compositional inhomogeneity between individual liposomes","author":"M\u00fcnter","year":"2019","journal-title":"J. Vis. Exp."},{"issue":"2023","key":"10.1016\/j.jconrel.2025.01.047_bb0095","first-page":"290","article-title":"Comment on \u201cOptimal centrifugal isolating of liposome\u2013protein complexes from human plasma\u201d by L. Digiacomo, F. Giulimondi, A. L. Capriotti, S. Piovesana, C. M. Montone, R. Z. Chiozzi, A. Lagan\u00e1, M. Mahmoudi, D. Pozzi and G. Caracciolo","volume":"5","author":"M\u00fcnter","year":"2021","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-5793(97)00905-8","article-title":"Immunoliposomes bearing polyethyleneglycol-coupled Fab\u2019 fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo","volume":"413","author":"Maruyama","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2007.11.005","article-title":"Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab\u2019 fragments and single chain Fv","volume":"126","author":"Cheng","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.01.047_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119792","article-title":"PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: faster PEG shedding attenuates anti-PEG IgM production","volume":"588","author":"Suzuki","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0079-6107(02)00052-4","article-title":"Fluid shear stress and the vascular endothelium: for better and for worse","volume":"81","author":"Resnick","year":"2003","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0120","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.4049\/jimmunol.181.9.6664","article-title":"Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b fc-associated effector functions","volume":"181","author":"Baudino","year":"2008","journal-title":"J. Immunol."},{"issue":"22","key":"10.1016\/j.jconrel.2025.01.047_bb0125","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","article-title":"Antibody\u2013drug conjugates come of age in oncology","volume":"8","author":"Dumontet","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ddtec.2018.07.002","article-title":"Minireview: addressing the retro-Michael instability of maleimide bioconjugates","volume":"30","author":"Szijj","year":"2018","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0135","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1021\/acs.chemrev.0c00928","article-title":"A Hitchhiker\u2019s guide to click-chemistry with nucleic acids","volume":"121","author":"Fantoni","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0140","doi-asserted-by":"crossref","first-page":"2110305","DOI":"10.1002\/adma.202110305","article-title":"Optimal Physicochemical Properties of Antibody\u2013Nanoparticle Conjugates for Improved Tumor Targeting","volume":"34","author":"Mittelheisser","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41570-019-0079-1","article-title":"Contemporary approaches to site-selective protein modification","volume":"3","author":"Hoyt","year":"2019","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0150","doi-asserted-by":"crossref","first-page":"9816","DOI":"10.1039\/D0NR08191D","article-title":"The conjugation strategy affects antibody orientation and targeting properties of nanocarriers","volume":"13","author":"Br\u00fcckner","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2025.01.047_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111643","article-title":"Influence of different conjugation methods for activating antibodies on polymeric nanoparticles: effects for polyclonal expansion of human CD8+ T cells","volume":"129","author":"Weller","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120966","article-title":"A simple, fast, and orientation-controllable technology for preparing antibody-modified liposomes","volume":"607","author":"Hirata","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.talanta.2005.02.018","article-title":"Protein G-liposomal nanovesicles as universal reagents for immunoassays","volume":"67","author":"Chen","year":"2005","journal-title":"Talanta"},{"key":"10.1016\/j.jconrel.2025.01.047_bb0170","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1039\/D0CS00310G","article-title":"Site-selective modification strategies in antibody\u2013drug conjugates","volume":"50","author":"Walsh","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0175","doi-asserted-by":"crossref","first-page":"9182","DOI":"10.1039\/D2CS00446A","article-title":"Non-internalising antibody\u2013drug conjugates","volume":"51","author":"Ashman","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-4939-9929-3_4","article-title":"Site-specific conjugation to Cys-engineered THIOMAB\u2122 antibodies","volume":"2078","author":"Adhikari","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0185","doi-asserted-by":"crossref","first-page":"14599","DOI":"10.1021\/jacs.8b09433","article-title":"Genetic incorporation of olefin cross-metathesis reaction tags for protein modification","volume":"140","author":"Bhushan","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0190","doi-asserted-by":"crossref","first-page":"11665","DOI":"10.1021\/acsnano.3c02195","article-title":"Mapping antibody domain exposure on nanoparticle surfaces using DNA-PAINT","volume":"17","author":"Tholen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.01.047_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.05.042","article-title":"The hard protein corona of stealth liposomes is sparse","volume":"307","author":"Kristensen","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.01.047_bb0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addr.2019.05.010","article-title":"Ligand density on nanoparticles: a parameter with critical impact on nanomedicine","volume":"143","author":"Alkilany","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314974","article-title":"The impact of Nanobody density on the targeting efficiency of PEGylated liposomes","volume":"23","author":"Mesquita","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.01.047_bb0210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2019.08.033","article-title":"Optimizing design parameters of a peptide targeted liposomal nanoparticle in an in vivo multiple myeloma disease model after initial evaluation in vitro","volume":"311\u2013312","author":"Stefanick","year":"2019","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925000586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925000586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T12:22:51Z","timestamp":1762258971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925000586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":42,"alternative-id":["S0168365925000586"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.047","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting antibodies dissociate from drug delivery liposomes during blood circulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}